EA202192199A1 - Композиции, содержащие коричную кислоту, и способы их применения - Google Patents
Композиции, содержащие коричную кислоту, и способы их примененияInfo
- Publication number
- EA202192199A1 EA202192199A1 EA202192199A EA202192199A EA202192199A1 EA 202192199 A1 EA202192199 A1 EA 202192199A1 EA 202192199 A EA202192199 A EA 202192199A EA 202192199 A EA202192199 A EA 202192199A EA 202192199 A1 EA202192199 A1 EA 202192199A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- cinnamic acid
- methods
- application
- compositions containing
- containing cinnamic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962810055P | 2019-02-25 | 2019-02-25 | |
| PCT/US2020/019568 WO2020176432A1 (en) | 2019-02-25 | 2020-02-25 | Compositions including cinnamic acid and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202192199A1 true EA202192199A1 (ru) | 2021-12-17 |
Family
ID=72238701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202192199A EA202192199A1 (ru) | 2019-02-25 | 2020-02-25 | Композиции, содержащие коричную кислоту, и способы их применения |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12478598B2 (enExample) |
| EP (1) | EP3930704A4 (enExample) |
| JP (1) | JP2022521233A (enExample) |
| KR (1) | KR20210130772A (enExample) |
| CN (1) | CN113473981A (enExample) |
| AU (1) | AU2020229316A1 (enExample) |
| CA (1) | CA3130761A1 (enExample) |
| EA (1) | EA202192199A1 (enExample) |
| WO (1) | WO2020176432A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202002639D0 (en) * | 2020-02-25 | 2020-04-08 | Ucl Business Ltd | Therapy |
| WO2022093922A1 (en) * | 2020-10-28 | 2022-05-05 | Rush University Medical Center | Use of a cinnamein composition for the treatment of glycine encephalopathy and urea cycle disorders |
| US20240350441A1 (en) * | 2021-12-01 | 2024-10-24 | Sava Healthcare Ltd | Pharmaceutical formulation and a process for its preparation |
| US20250057793A1 (en) * | 2021-12-16 | 2025-02-20 | The United States Government As Represented By The Department Of Veterans Affairs | Benzoic acid salts for treatment of nervous system injuries and disorders |
| WO2024201533A1 (en) * | 2023-03-31 | 2024-10-03 | Sava Healthcare Limited | A parenteral composition of cinnamic acid |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100479405B1 (ko) * | 2002-05-24 | 2005-03-30 | 주식회사 싸이제닉 | 신남산 이합체, 그 제조방법 및 퇴행성 뇌질환 치료를위한 그의 용도 |
| HUE053671T2 (hu) * | 2014-01-17 | 2021-07-28 | Univ Rush Medical Center | Gliceril-tribenzoátot tartalmazó készítmény neurodegeneratív rendellenességben történõ alkalmazása |
| ES2799309T3 (es) * | 2014-09-29 | 2020-12-16 | Cellix Bio Private Ltd | Compuestos y composiciones para el tratamiento de esclerosis múltiple |
| EP4026545A1 (en) * | 2014-11-19 | 2022-07-13 | Rush University Medical Center | Compositions and methods for treating lysosomal disorders |
| WO2017215593A1 (en) | 2016-06-13 | 2017-12-21 | Syneurx International (Taiwan) Corp. | Co-crystals of sodium benzoate and uses thereof |
| EP3691630A4 (en) * | 2017-10-06 | 2021-10-27 | Rush University Medical Center | USE OF A COMPOSITION CONTAINING BENZOATE TO TREAT GLYCINE ENCEPHALOPATHY |
| GB202002639D0 (en) | 2020-02-25 | 2020-04-08 | Ucl Business Ltd | Therapy |
| WO2022093922A1 (en) * | 2020-10-28 | 2022-05-05 | Rush University Medical Center | Use of a cinnamein composition for the treatment of glycine encephalopathy and urea cycle disorders |
| EP4281118A4 (en) * | 2021-01-20 | 2025-01-01 | Rush University Medical Center | Improved treatment for globoid cell leukodsytrophy or krabbe disease |
-
2020
- 2020-02-25 EA EA202192199A patent/EA202192199A1/ru unknown
- 2020-02-25 CN CN202080016447.1A patent/CN113473981A/zh active Pending
- 2020-02-25 KR KR1020217030331A patent/KR20210130772A/ko not_active Withdrawn
- 2020-02-25 JP JP2021548664A patent/JP2022521233A/ja not_active Withdrawn
- 2020-02-25 US US17/433,730 patent/US12478598B2/en active Active
- 2020-02-25 CA CA3130761A patent/CA3130761A1/en active Pending
- 2020-02-25 EP EP20763119.3A patent/EP3930704A4/en active Pending
- 2020-02-25 WO PCT/US2020/019568 patent/WO2020176432A1/en not_active Ceased
- 2020-02-25 AU AU2020229316A patent/AU2020229316A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN113473981A (zh) | 2021-10-01 |
| EP3930704A4 (en) | 2022-11-16 |
| US20220133664A1 (en) | 2022-05-05 |
| KR20210130772A (ko) | 2021-11-01 |
| US12478598B2 (en) | 2025-11-25 |
| AU2020229316A1 (en) | 2021-09-16 |
| EP3930704A1 (en) | 2022-01-05 |
| WO2020176432A1 (en) | 2020-09-03 |
| CA3130761A1 (en) | 2020-09-03 |
| JP2022521233A (ja) | 2022-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202190960A1 (ru) | Конденсированные пирролины, которые действуют как ингибиторы убиквитин-специфической протеазы 30 (usp30) | |
| JOP20200154A1 (ar) | مركبات ومشتقات بيريدو بيريمينون بها استبدال ببنزيل أمينو جديدة كمثبطات sos1 | |
| EA201891103A1 (ru) | Композиции для лечения спинальной мышечной атрофии | |
| PH12021551065A1 (en) | Fused ring compounds | |
| EA202090573A1 (ru) | Составы нирапариба | |
| MX388457B (es) | Inhibidores de imidazopirazina de la tirosina cinasa de bruton. | |
| EA201992116A1 (ru) | Фармацевтические составы флороглюцинола и триметилфлороглюцинола | |
| EA202090486A2 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| EA201890767A1 (ru) | C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений | |
| EA201890654A1 (ru) | Терапевтические композиции для лечения вируса иммунодефицита человека | |
| EA202192905A1 (ru) | Соединения, содержащие n-метил-2-пиридон, и фармацевтически приемлемые соли | |
| EA201491606A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| EA202191955A1 (ru) | Таблетированные составы с модифицированным высвобождением, содержащие ингибиторы фосфодиэстеразы | |
| JOP20200041A1 (ar) | تركيبات صيدلية تحتوي على أجسام مضادة لبيتا نشوي | |
| EA202191239A1 (ru) | Соединения и их применение для лечения дефицита 1-антитрипсина | |
| EA201991387A1 (ru) | ТРИЦИКЛИЧЕСКИЕ ЕНОНЫ - ПРОИЗВОДНЫЕ ПИРИМИДИНА ДЛЯ ИНГИБИРОВАНИЯ ROR-γ И ДРУГИХ ПРИМЕНЕНИЙ | |
| EA202190588A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
| CL2020001020A1 (es) | Derivados de bencimidazol y sus usos. | |
| EA201791432A1 (ru) | Композиции на основе пролекарства монометилфумарата | |
| EA202191478A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
| EA202192925A1 (ru) | Твердые формы ингибитора glyt1 | |
| EA201890534A1 (ru) | Новые аннелированные феноксиацетамиды | |
| EA202092326A1 (ru) | Производные буметанида для лечения гипергидроза | |
| EA202091604A1 (ru) | Ингибирование ионного канала a1 с транзиторным рецепторным потенциалом | |
| EA202092335A1 (ru) | Композиции на основе эренумаба и пути их применения |